| Title |
Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle
|
|---|---|
| Published in |
PLOS ONE, January 2008
|
| DOI | 10.1371/journal.pone.0001501 |
| Pubmed ID | |
| Authors |
Rick A. Bright, Donald M. Carter, Corey J. Crevar, Franklin R. Toapanta, Jonathan D. Steckbeck, Kelly S. Cole, Niranjan M. Kumar, Peter Pushko, Gale Smith, Terrence M. Tumpey, Ted M. Ross |
| Abstract |
Vaccination is a cost-effective counter-measure to the threat of seasonal or pandemic outbreaks of influenza. To address the need for improved influenza vaccines and alternatives to egg-based manufacturing, we have engineered an influenza virus-like particle (VLP) as a new generation of non-egg or non-mammalian cell culture-based candidate vaccine. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| French Polynesia | 1 | <1% |
| Bangladesh | 1 | <1% |
| Netherlands | 1 | <1% |
| India | 1 | <1% |
| Canada | 1 | <1% |
| Egypt | 1 | <1% |
| Mexico | 1 | <1% |
| Argentina | 1 | <1% |
| Unknown | 123 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 37 | 28% |
| Student > Ph. D. Student | 18 | 14% |
| Student > Master | 17 | 13% |
| Other | 9 | 7% |
| Student > Bachelor | 7 | 5% |
| Other | 18 | 14% |
| Unknown | 25 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 59 | 45% |
| Biochemistry, Genetics and Molecular Biology | 10 | 8% |
| Medicine and Dentistry | 9 | 7% |
| Immunology and Microbiology | 9 | 7% |
| Engineering | 7 | 5% |
| Other | 11 | 8% |
| Unknown | 26 | 20% |